BC
BIT Capital Portfolio holdings
AUM
$1.53B
1-Year Est. Return
78.29%
1 Year Est. Return
+78.29%
AUM
$830M
AUM Growth
-$312M
(-27%)
Holding
125
Top Buys
| 1 | +$44.5M | |
| 2 | +$26.1M | |
| 3 | +$18.5M | |
| 4 |
Duolingo
DUOL
|
+$14.3M |
| 5 |
BridgeBio Pharma
BBIO
|
+$9.77M |
Top Sells
| 1 | +$34.3M | |
| 2 | +$30.4M | |
| 3 | +$29.7M | |
| 4 |
Kaspi.kz JSC
KSPI
|
+$25.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$23.6M |
Sector Composition
| 1 | Technology | 32.44% |
| 2 | Financials | 28.68% |
| 3 | Healthcare | 18.27% |
| 4 | Consumer Discretionary | 16.41% |
| 5 | Communication Services | 4.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
CleanSpark
CLSK
$5.62B
| $3.93M | 0.34% |
585,246
-29,931
|
|
||
27
NVIDIA
NVDA
$4.43T
| $2.19M | 0.19% |
20,205
-316,226
|
|
||
28
Credicorp
BAP
$20.1B
| $1.82M | 0.16% |
9,776
+1,071
|
|
||
29
Grab
GRAB
$23.3B
| $1.78M | 0.15% |
393,961
+7,297
|
|
||
30
Scholar Rock
SRRK
$2.83B
| $1.37M | 0.12% |
42,694
-22,621
|
|
||
|
SWTX
31
DELISTED
SpringWorks Therapeutics
SWTX
| $1.34M | 0.11% |
30,257
-23,282
|
|
||
32
Merus
MRUS
$7.19B
| $1.25M | 0.11% |
29,612
+8,210
|
|
||
33
Immunocore
IMCR
$1.69B
| $1.21M | 0.1% |
40,787
-27,053
|
|
||
34
argenx
ARGX
$51.6B
| $1.09M | 0.09% |
1,847
-2,185
|
|
||
35
Microsoft
MSFT
$3.8T
| $999K | 0.09% |
2,662
-17,069
|
|
||
36
Palo Alto Networks
PANW
$139B
| $979K | 0.08% |
5,739
+4,877
|
|
||
37
JPMorgan Chase
JPM
$813B
| $973K | 0.08% |
3,965
+1,323
|
|
||
38
Viridian Therapeutics
VRDN
$1.88B
| $966K | 0.08% |
71,680
-214,274
|
|
||
39
Axon Enterprise
AXON
$51.2B
| $966K | 0.08% |
1,836
-2,625
|
|
||
40
BioNTech
BNTX
$25.3B
| $964K | 0.08% |
10,586
-8,894
|
|
||
41
Day One Biopharmaceuticals
DAWN
$765M
| $924K | 0.08% |
116,565
-55,149
|
|
||
42
Rubrik
RBRK
$15.5B
| $790K | 0.07% |
12,960
-2,288
|
|
||
43
Ultragenyx Pharmaceutical
RARE
$3.27B
| $784K | 0.07% |
21,655
-8,215
|
|
||
|
CMPS
44
Compass Pathways
CMPS
$615M
| $704K | 0.06% |
246,320
+130,623
|
|
||
45
IDEAYA Biosciences
IDYA
$2.43B
| $700K | 0.06% |
42,715
-20,957
|
|
||
46
Sea Limited
SE
$96.3B
| $678K | 0.06% |
5,195
-3,672
|
|
||
47
Agios Pharmaceuticals
AGIO
$2.41B
| $629K | 0.05% |
+21,468
|
|
||
48
ATAI Life Sciences
ATAI
$1.28B
| $597K | 0.05% |
+439,107
|
|
||
49
Xenon Pharmaceuticals
XENE
$3.25B
| $582K | 0.05% |
17,352
-36,576
|
|
||
50
MoonLake Immunotherapeutics
MLTX
$596M
| $571K | 0.05% |
14,610
-6,138
|
|